Accordingly, tRCC lines showed marked sensitivity to GPX4 inhibition with IC50 values in the nanomolar range similar to renal medullary carcinoma lines (Vokshi et al, 2023). This evidence concerns the gene GPX4 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.